S 
Sun Pharmaceutical Industries Ltd SUNPHARMA.NS · INR
Pharmaceuticals · NSE · 🇮🇳 India
Nifty 50
1,904.50
+2.39%
Close of 9 Nov 2026, in INR
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in INR, from our data supplier.
Revenue
₹582.20bn
FY2017FY2026
Net income
₹114.79bn
FY2017FY2026
Free cash flow
₹88.10bn
FY2017FY2026
Shareholders' equity
₹835.70bn
FY2017FY2026
Income statement
Fiscal years
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ₹582.20bn | ₹525.78bn | ₹484.97bn | ₹438.86bn | ₹386.54bn | ₹334.98bn | ₹328.38bn | ₹290.66bn | ₹264.89bn | ₹315.78bn |
| Gross profit | ₹450.47bn | ₹403.81bn | ₹364.27bn | ₹319.43bn | ₹269.47bn | ₹236.13bn | ₹223.66bn | ₹198.27bn | ₹175.90bn | ₹218.83bn |
| Operating income | ₹135.95bn | ₹139.83bn | ₹113.26bn | ₹95.80bn | ₹35.78bn | ₹21.47bn | ₹47.69bn | ₹36.88bn | ₹33.83bn | ₹86.26bn |
| Net income | ₹114.79bn | ₹109.29bn | ₹95.76bn | ₹84.74bn | ₹32.73bn | ₹29.04bn | ₹37.65bn | ₹26.65bn | ₹20.96bn | ₹69.64bn |
| Diluted earnings per share | 47.84 | 45.55 | 39.91 | 35.32 | 13.64 | 12.13 | 15.65 | 11.12 | 8.74 | 29.02 |
Balance sheet
At each fiscal year end
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | ₹1.09trn | ₹921.01bn | ₹855.00bn | ₹807.44bn | ₹698.08bn | ₹676.67bn | ₹682.52bn | ₹646.94bn | ₹645.16bn | ₹614.10bn |
| Cash and short-term investments | — | ₹250.33bn | ₹191.14bn | ₹151.48bn | ₹127.17bn | ₹95.63bn | ₹113.67bn | ₹111.83bn | ₹139.77bn | ₹153.51bn |
| Total liabilities | ₹249.05bn | ₹196.15bn | ₹218.33bn | ₹247.48bn | ₹217.97bn | ₹212.04bn | ₹229.88bn | ₹232.85bn | ₹262.02bn | ₹247.71bn |
| Debt | — | ₹23.62bn | ₹32.74bn | ₹68.86bn | ₹12.90bn | ₹38.69bn | ₹83.15bn | ₹105.14bn | ₹103.85bn | ₹98.32bn |
| Shareholders' equity | ₹835.70bn | ₹722.18bn | ₹636.67bn | ₹559.95bn | ₹480.11bn | ₹464.63bn | ₹452.64bn | ₹414.09bn | ₹383.14bn | ₹366.40bn |
| Shares outstanding | 2,399m | 2,399m | 2,399m | 2,399m | 2,399m | 2,394m | 2,406m | 2,398m | 2,397m | 2,400m |
Cash flow
Fiscal years
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | ₹124.19bn | ₹140.72bn | ₹121.36bn | ₹55.26bn | ₹89.85bn | ₹61.70bn | ₹65.55bn | ₹21.96bn | ₹39.07bn | ₹70.82bn |
| Capital spending | −₹36.09bn | −₹21.29bn | −₹22.02bn | −₹20.86bn | −₹14.95bn | −₹11.70bn | −₹15.42bn | −₹32.13bn | −₹19.61bn | −₹36.93bn |
| Free cash flow | ₹88.10bn | ₹119.43bn | ₹99.34bn | ₹34.40bn | ₹74.89bn | ₹50.00bn | ₹50.13bn | −₹10.16bn | ₹19.46bn | ₹33.89bn |
| Dividends paid | −₹39.34bn | −₹36.14bn | −₹28.98bn | −₹25.19bn | −₹21.59bn | −₹15.59bn | −₹13.79bn | −₹4.80bn | −₹7.98bn | −₹2.40bn |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹151.84bn | ₹145.60bn | ₹155.21bn | ₹144.78bn | ₹138.51bn | ₹129.59bn | ₹136.75bn | ₹132.91bn |
| Gross profit | ₹122.20bn | ₹117.59bn | ₹125.75bn | ₹114.96bn | ₹110.37bn | ₹103.22bn | ₹109.35bn | ₹105.97bn |
| Operating income | ₹35.57bn | ₹27.52bn | ₹43.06bn | ₹33.67bn | ₹32.48bn | ₹33.03bn | ₹35.28bn | ₹36.67bn |
| Net income | ₹28.95bn | ₹27.14bn | ₹33.69bn | ₹31.18bn | ₹22.79bn | ₹21.50bn | ₹29.03bn | ₹30.40bn |
| Diluted earnings per share | 12.06 | 11.31 | 14.04 | 13.00 | 9.50 | 8.96 | 12.10 | 12.67 |
| Cash from operations | — | — | — | ₹49.44bn | — | ₹140.72bn | — | ₹62.99bn |
| Capital spending | — | — | — | −₹23.88bn | — | −₹21.29bn | — | −₹6.97bn |
| Free cash flow | — | — | — | ₹25.55bn | — | ₹119.44bn | — | ₹56.02bn |
| Total assets | — | ₹1.09trn | — | ₹1.04trn | — | ₹921.01bn | — | ₹881.16bn |
| Cash and short-term investments | — | — | — | ₹294.01bn | — | ₹267.28bn | — | ₹207.55bn |
| Debt | — | ₹312.6m | — | ₹3.62bn | — | ₹3.58bn | — | ₹3.68bn |
| Shareholders' equity | — | ₹835.70bn | — | ₹778.20bn | — | ₹722.18bn | — | ₹691.15bn |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 9.9% | 11.7% | 7.4% |
| Operating income | 12.4% | 44.7% | 7.1% |
| Net income | 10.6% | 31.6% | 9.7% |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Gross margin | 77.1% | 75.7% | 74.2% | 72.4% |
| Operating margin | 24.9% | 23.9% | 19.7% | 19.2% |
| Net margin | 20.2% | 19.9% | 16.9% | 15.7% |
Valuation history
At each fiscal year end
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings | 38.1 | 37.8 | 47.3 | 35.7 | 73.3 | 69.7 | 37.7 | 38.9 | 49.2 | 19.6 |
| Price to sales | 7.5 | 7.8 | 9.3 | 6.9 | 6.2 | 6.0 | 4.3 | 3.6 | 3.9 | 4.3 |
Dividends and splits
Per share, in the currency the company pays
Paid for 25 years. Last went ex-dividend on 7 Jul 2026.
| FY2027 | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|---|---|
| Paid in the year | 5.00 | 16.50 | 15.50 | 12.50 | 10.50 | 9.00 | 6.50 | 5.75 |
- 2-for-1 split · 29 Jul 2013
- 5-for-1 split · 25 Nov 2010
- 2-for-1 split · 27 May 2004
- 2-for-1 split · 13 Jan 2003
- 3-for-1 split · 6 Mar 2000
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.